Todd Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$932K Hold
3,182
0.02% 147
2025
Q4
$1.12M Hold
3,182
0.02% 147
2025
Q3
$1.03M Hold
3,182
0.02% 146
2025
Q2
$1.24M Hold
3,182
0.03% 137
2025
Q1
$1.38M Sell
3,182
-20
-0.6% -$8.03K 0.03% 133
2024
Q4
$1.18M Sell
3,202
-66,271
-95% -$27.7M 0.03% 135
2024
Q3
$36.1M Sell
69,473
-415
-0.6% -$222K 0.84% 53
2024
Q2
$37.9M Buy
69,888
+14,362
+26% +$7.59M 0.79% 50
2024
Q1
$28.8M Sell
55,526
-4,380
-7% -$2.18M 0.59% 81
2023
Q4
$28.2M Buy
59,906
+8,413
+16% +$3.89M 0.62% 70
2023
Q3
$22.4M Sell
51,493
-10,477
-17% -$4.75M 0.53% 80
2023
Q2
$27.5M Sell
61,970
-12,441
-17% -$5.74M 0.64% 64
2023
Q1
$34.2M Sell
74,411
-38,600
-34% -$18.4M 0.83% 38
2022
Q4
$58M Buy
113,011
+760
+0.7% +$386K 1.41% 9
2022
Q3
$51M Buy
112,251
+36,855
+49% +$17.6M 1.43% 9
2022
Q2
$36.4M Buy
75,396
+141
+0.2% +$69.8K 0.94% 25
2022
Q1
$37M Buy
75,255
+9,234
+14% +$4.22M 0.81% 37
2021
Q4
$30.6M Sell
66,021
-3,263
-5% -$1.37M 0.66% 62
2021
Q3
$25.8M Sell
69,284
-424
-0.6% -$161K 0.59% 72
2021
Q2
$26.6M Buy
69,708
+182
+0.3% +$69.6K 0.6% 71
2021
Q1
$25M Sell
69,526
-247
-0.4% -$79.4K 0.59% 79
2020
Q4
$22.4M Sell
69,773
-3,802
-5% -$1.17M 0.57% 78
2020
Q3
$19.8M Buy
73,575
+12
+0% +$3.23K 0.59% 70
2020
Q2
$19.3M Sell
73,563
-5,753
-7% -$1.53M 0.61% 71
2020
Q1
$18M Sell
79,316
-10,208
-11% -$2.78M 0.69% 59
2019
Q4
$27M Sell
89,524
-870
-1% -$239K 0.67% 57
2019
Q3
$21.7M Sell
90,394
-25,110
-22% -$6.88M 0.59% 68
2019
Q2
$32.6M Sell
115,504
-411
-0.4% -$112K 0.89% 29
2019
Q1
$33.3M Sell
115,915
-18,031
-13% -$5.21M 0.94% 27
2018
Q4
$35.2M Buy
133,946
+7,561
+6% +$2.08M 1.13% 15
2018
Q3
$34.6M Sell
126,385
-1,246
-1% -$323K 0.95% 27
2018
Q2
$30.4M Sell
127,631
-69,193
-35% -$16M 0.85% 33
2018
Q1
$43.2M Buy
196,824
+59,911
+44% +$14.1M 1.19% 17
2017
Q4
$30.8M Sell
136,913
-4,880
-3% -$1.04M 0.83% 36
2017
Q3
$26.9M Sell
141,793
-6,058
-4% -$1.15M 0.75% 45
2017
Q2
$27.8M Sell
147,851
-5,534
-4% -$994K 0.79% 37
2017
Q1
$25.4M Sell
153,385
-10,363
-6% -$1.65M 0.73% 39
2016
Q4
$23.5M Sell
163,748
-12,589
-7% -$1.69M 0.71% 47
2016
Q3
$22.1M Sell
176,337
-55,974
-24% -$7.23M 0.67% 52
2016
Q2
$30.5M Sell
232,311
-41,364
-15% -$5.66M 0.97% 30
2016
Q1
$38M Buy
273,675
+67,931
+33% +$9.08M 1.13% 18
2015
Q4
$28.7M Sell
205,744
-8,539
-4% -$1.18M 0.87% 40
2015
Q3
$30M Sell
214,283
-6,075
-3% -$913K 0.94% 36
2015
Q2
$36.2M Buy
220,358
+36,488
+20% +$5.83M 0.98% 32
2015
Q1
$28.4M Sell
183,870
-878
-0.5% -$125K 0.79% 41
2014
Q4
$23.2M Sell
184,748
-339
-0.2% -$41.9K 0.65% 49
2014
Q3
$22.1M Buy
185,087
+83,707
+83% +$9.6M 0.63% 53
2014
Q2
$10.9M Buy
+101,380
New +$10.4M 0.31% 110
2014
Q1
Sell
-69,154
Closed -$6.39M 203
2013
Q4
$6.39M Buy
69,154
+4,064
+6% +$361K 0.19% 132
2013
Q3
$5.44M Buy
65,090
+34,600
+113% +$2.97M 0.17% 142
2013
Q2
$2.5M Buy
+30,490
New +$2.28M 0.08% 138

Other funds holding ELV

Todd Asset Management's ELV Position: Q1 2026 in Review

Todd Asset Management held its Elevance Health (ELV) position steady in Q1 2026 at 3,182 shares worth $932K. The position accounts for 0.02% of the portfolio, ranked #147.

Todd Asset Management first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $58M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Todd Asset Management held 3,182 shares of Elevance Health worth $932K as of Q1 2026.
  • Todd Asset Management left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.02% of Todd Asset Management's portfolio in Q1 2026, its #147 holding.
  • Todd Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Todd Asset Management's Elevance Health position peaked at $58M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Todd Asset Management's 13F filing for Q1 2026, filed 12 May 2026.